Abbruzzese-1994

MethodsRetrospective case series
Participants and Country657 patients with unknown primary cancer. (excluding SCC of upper/mid neck nodes)
InterventionsThere was no uniform treatment
OutcomesOverall survival
Prognostic factors (univariate)Age, sex, race, number of sites, anatomical site, histology (adenocarcinoma, carcinoma, SCC or neuroendocrine carcinoma)
Prognostic factors (multivariate)Reported only significant prognostic factors: sex, number of sites, anatomical site, histology (adenocarcinoma or neuroendocrine carcinoma)
Notes

From: Guideline chapter 3, Factors Influencing Management

Cover of Diagnosis and Management of Metastatic Malignant Disease of Unknown Primary Origin
Diagnosis and Management of Metastatic Malignant Disease of Unknown Primary Origin.
NICE Clinical Guidelines, No. 104.
National Collaborating Centre for Cancer (UK).
Copyright © 2010, National Collaborating Centre for Cancer.

No part of this publication may be reproduced, stored or transmitted in any form or by any means, without the prior written permission of the publisher or, in the case of reprographic reproduction, in accordance with the terms of licenses issued by the Copyright Licensing Agency in the UK. Enquiries concerning reproduction outside the terms stated here should be sent to the publisher at the UK address printed on this page.

The use of registered names, trademarks etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant laws and regulations and therefore for general use.

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.